Patents Assigned to INTER SCIENCE GMBH
-
Patent number: 12127779Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A pulse that has an element of decay may be applied to a target for tissue ablation while the decay is modulated. In some examples, apparatus including a controller and switches may be used to modulate the decay and/or selectively apply the pulse to the target. The apparatus may further include resistors and/or other elements to modulate a magnitude of the pulse and/or a slope of a decay of the pulse.Type: GrantFiled: September 4, 2019Date of Patent: October 29, 2024Assignee: Inter Science GmbHInventors: Enric Günther, Boris Rubinsky, Nina Klein, Paul Mikus, Michael Stehling
-
Publication number: 20240065749Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: ApplicationFiled: November 6, 2023Publication date: February 29, 2024Applicants: Inter Science GmbH, RM2 Technology LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther
-
Patent number: 11857244Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: GrantFiled: March 8, 2021Date of Patent: January 2, 2024Assignees: Inter Science GmbH, RM2 Technology LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther
-
Publication number: 20210330371Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A pulse that has an element of decay may be applied to a target for tissue ablation while the decay is modulated. In some examples, apparatus including a controller and switches may be used to modulate the decay and/or selectively apply the pulse to the target. The apparatus may further include resistors and/or other elements to modulate a magnitude of the pulse and/or a slope of a decay of the pulse.Type: ApplicationFiled: September 4, 2019Publication date: October 28, 2021Applicant: Inter Science GmbHInventors: Enric Günther, Boris Rubinsky, Nina Klein, Paul Mikus, Michael Stehling
-
Publication number: 20210186592Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: ApplicationFiled: March 8, 2021Publication date: June 24, 2021Applicants: INTER SCIENCE GMBH, RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther
-
Patent number: 10939949Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: GrantFiled: May 13, 2015Date of Patent: March 9, 2021Assignees: INTER SCIENCE GMBH, RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther
-
Publication number: 20180193082Abstract: Example methods and apparatuses are disclosed for providing tissue ablation through electrolysis, electroporation, or a combination thereof. A way to deliver the combination through a pulse that has an element of gradual decay and can thereby reduce both muscle contraction and electric breakdown discharge at the electrodes is disclosed. The apparatus disclosed may include an electrode, a power supply, and a controller. The controller may control a charge applied to the electrode to induce a direct current through a treatment site to produce electrolysis products and a voltage to produce electroporation. The duration and magnitude of the charge applied may determine the dose of the products and the degree of the permeabilization of cells in the treatment site.Type: ApplicationFiled: May 13, 2015Publication date: July 12, 2018Applicants: INTER SCIENCE GMBH, RM2 TECHNOLOGY LLCInventors: Boris Rubinsky, Paul Mikus, Liel Rubinsky, Michael Klaus Stehling, Enric Günther